A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Study ID
NCT02301286

Study type
Interventional

Study phase
Phase 3

Study status
Active, not recruiting

Trial Acronym

ASPIRIN

Trial Summary

The purpose of this study is to determine whether acetylsalicylic acidis effective on the recurrence and survival of colon cancer patients.

More informations

Trial Starting Date

Jan 31,2015

Requirements

Gender All
Minimum age 45 Years
Maximum age N/A

Enrollement Limit

770